Merit Medical Systems Inc.

MMSI | NASDAQ

Price Alert Chart Builder DCF Calculator

$87.26

+$1.77 (+2.07%)

At close: Sep 22, 2026, 4:00 PM ET

$87.26

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.1B

Enterprise Value $5.52B

Beta 0.49

Average Volume 888.18K

Shares Outstanding (Diluted) 60.01M

Shares Change YoY -0.99%

Institutional Ownership 99.96%

Exchange NASDAQ

ISIN US5898891040

Price Performance

Price Change 1M -6.0%

Price Change 3M 27.1%

Price Change 6M 25.5%

Price Change YTD -1.1%

Price Change 1Y 2.3%

Price Change 3Y 25.5%

Price Change 5Y 18.3%

1M CAGR (ann.) -4.0%

1Y CAGR (ann.) 1.6%

5Y CAGR (ann.) 3.6%

All-Time CAGR 10.1%

Valuation

PE Ratio 35.33

Forward PE 17.83

PEG Ratio 1.69

Forward PEG 4.86

PS Ratio 3.23

Forward PS 2.90

PB Ratio 3.04

P/FCF Ratio 21.41

P/Adj. FCF Ratio 26.44

P/OCF Ratio 18.00

EV/Sales 3.50

EV/EBIT 33.93

EV/EBITDA 21.45

EV/FCF 23.16

Earnings Yield 2.8%

FCF Yield 4.7%

Adj. FCF Yield 3.8%

Financial Health

Net Debt $418.51M

Total Debt $867.21M

Cash & Short-Term Investments $448.7M

Total Assets $2.86B

Current Ratio 4.20

Quick Ratio 2.79

Debt / Equity Ratio 0.49

Debt / EBITDA 3.37

Debt / FCF 3.64

OCF / Debt 0.33

Interest Coverage 6.34

Altman Z-Score 4.12

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 49.5%

Operating Profit Margin 12.7%

EBITDA Margin 22.9%

Net Profit Margin 9.2%

FCF Margin 15.1%

Adj. FCF Margin 12.2%

SBC / Revenue 2.9%

SBC Impact (per share) -19.0%

Returns

Return on Assets 5.1%

Return on Equity 9.1%

Return on Invested Capital 5.8%

Return on Capital Employed 7.8%

Return on Tangible Assets 8.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 9.6%

Revenue CAGR 5Y 8.9%

Revenue CAGR 10Y 10.8%

EPS CAGR 3Y 15.8%

EPS CAGR 5Y 37.1%

EPS CAGR 10Y 16.9%

FCF CAGR 3Y 69.7%

FCF CAGR 5Y 12.5%

FCF CAGR 10Y 45.4%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 15

EPS Growth Next 3Y 28.5%

Revenue Growth Next 3Y 7.3%

Earnings Date Oct 28, 2026

EPS Estimate (next Q) $1.04

EPS Growth Est (next Q) 13.0%

Revenue Est (next Q) $410.38M

Revenue Growth Est (next Q) 6.8%

Fair Value Estimates

Graham Number $39.15

Graham Upside -54.2%

Lynch Fair Value $60.50

Lynch Upside -29.2%

Price Target $101.88

Price Target Upside 19.2%

Cash Flow

Operating Cash Flow $283.45M

Free Cash Flow $238.46M

Adj. Free Cash Flow $193.08M

FCF Per Share $3.41

OCF Per Share $4.75

OCF/S Ratio 17.9%

Income Statement

Revenue $1.58B

Gross Profit $781.93M

Operating Income $200.81M

EBITDA $257.5M

Net Income $145.56M

EPS (Diluted) $2.42

Revenue / Employee $210.56K

Profit / Employee $19.41K

Employees 7,500